1. Home
  2. OPY vs IRMD Comparison

OPY vs IRMD Comparison

Compare OPY & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPY
  • IRMD
  • Stock Information
  • Founded
  • OPY 1881
  • IRMD 1992
  • Country
  • OPY United States
  • IRMD United States
  • Employees
  • OPY N/A
  • IRMD N/A
  • Industry
  • OPY Investment Bankers/Brokers/Service
  • IRMD Medical/Dental Instruments
  • Sector
  • OPY Finance
  • IRMD Health Care
  • Exchange
  • OPY Nasdaq
  • IRMD Nasdaq
  • Market Cap
  • OPY 638.4M
  • IRMD 662.5M
  • IPO Year
  • OPY N/A
  • IRMD 2014
  • Fundamental
  • Price
  • OPY $52.65
  • IRMD $49.75
  • Analyst Decision
  • OPY
  • IRMD Strong Buy
  • Analyst Count
  • OPY 0
  • IRMD 1
  • Target Price
  • OPY N/A
  • IRMD $72.00
  • AVG Volume (30 Days)
  • OPY 25.7K
  • IRMD 34.8K
  • Earning Date
  • OPY 04-25-2025
  • IRMD 05-01-2025
  • Dividend Yield
  • OPY 1.27%
  • IRMD 1.32%
  • EPS Growth
  • OPY 145.95
  • IRMD 11.11
  • EPS
  • OPY 6.37
  • IRMD 1.50
  • Revenue
  • OPY $1,344,515,000.00
  • IRMD $73,242,121.00
  • Revenue This Year
  • OPY N/A
  • IRMD $10.58
  • Revenue Next Year
  • OPY N/A
  • IRMD $17.74
  • P/E Ratio
  • OPY $9.47
  • IRMD $35.73
  • Revenue Growth
  • OPY 13.93
  • IRMD 11.71
  • 52 Week Low
  • OPY $36.93
  • IRMD $40.18
  • 52 Week High
  • OPY $73.12
  • IRMD $63.29
  • Technical
  • Relative Strength Index (RSI)
  • OPY 22.20
  • IRMD 38.53
  • Support Level
  • OPY $58.16
  • IRMD $51.16
  • Resistance Level
  • OPY $60.46
  • IRMD $54.10
  • Average True Range (ATR)
  • OPY 1.37
  • IRMD 1.31
  • MACD
  • OPY -0.58
  • IRMD 0.18
  • Stochastic Oscillator
  • OPY 0.00
  • IRMD 17.33

About OPY Oppenheimer Holdings Inc. (DE)

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: